Acta Med. 2006, 49: 175-181
https://doi.org/10.14712/18059694.2017.128
Possibilities of Combined Surgical Treatment of Lung Tumours and Heart Diseases
References
1. J, Leatche M, Agnihotri A, Bueno R. The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies. Chest 2004; 125:1581–6.
<https://doi.org/10.1378/chest.125.4.1581>
2. Y, Morioka R, Muraoka A, Ihaya T. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1998; 65(1):107–13.
<https://doi.org/10.1016/S0003-4975(97)01111-9>
3. RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990; 49:32–4.
<https://doi.org/10.1016/0003-4975(90)90352-7>
4. C, Knoentgen J, Anagnostopoulos C. Median sternotomy for pneumonectomy in patients with pulmonary complications of tuberculosis. Ann Thorac Surg 2003; 75:1613–17.
<https://doi.org/10.1016/S0003-4975(02)04901-9>
5. JD, Nelems JM, Pearson FG. Extended indications for median sternotomy in patients requiring pulmonary resection. Ann Thorac Surg 1978; 26:413–9.
<https://doi.org/10.1016/S0003-4975(10)62919-0>
6. M, Anikin V, McManus KG, McGiuganJA, Campalani G. Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of leterature. Europ J of Cardiothor Surg 1998;(13):667–72.
<https://doi.org/10.1016/S1010-7940(98)00088-8>
7. R, Hill A.B. Smoking and carcinoma of the lung. BMJ, 1950; 221,739–48.
<https://doi.org/10.1136/bmj.2.4682.739>
<PubMed>
8. G, Leilani F, Madhu V, Wilson K. Neutrophil leukotrine generation increases after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108:642–7.
9. W, Jemielity M, Piwkowski C, Perek B, Kasprzyk M. Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting). Ann Thorac Surg 2004; 77:1023–7.
<https://doi.org/10.1016/j.athoracsur.2003.07.041>
10. G, Leilani F, Madhu V, Wilson K. Neutrophil leukotrine generation increases after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108:642–7.
11. A, Korach A, Rudis E. Lung cancer resection or aortic graft replacement with simultaneous myocardial revascularization without cardiopulmonary bypass. Chest 2001; 119:1941–3.
<https://doi.org/10.1378/chest.119.6.1941>
12. A. Příspěvek ke studiu vlivu kouření cigaret na nálezy v pitevním materiálu. Suppl sbor věd Prací LF UK Hradec Králové 1973; 16(2):137–54.
13. EA, Singer I. Succesfull removal of an entire lung for carcinoma of the bronchus. J Amer Med Ass 1993; 1001:1371–3.
14. Hiatt HH. Origins of human cancer. Book C: Human risk assesement. Cold Spring Harbor Conferences on Cell Protection. Cold Spring Harbor Laboratory 1977.
15. Y, Morioka R, Muraoka A, Ihaya T. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1998; 65(1):107–113.
<https://doi.org/10.1016/S0003-4975(97)01111-9>
16. M, Langton E, Taylor N, Misso M. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 118(5):930–7.
<https://doi.org/10.1016/S0022-5223(99)70064-4>
17. RH, Storgaard M, Vedesldal R, Obel N. Imparied neutrophil chemotaxis after cardiac surgery. Scand J Thorac Cardiovasc Surg 1995; 29:115–8.
<https://doi.org/10.3109/14017439509107216>
18. C, Sarikaya S, Zengin M, Atasalihi A. Combined off-pump coronary revascularization and lung resection. Acta Med (Hradec Králové) 2002; 45(3):119–21.
19. F, Anderson L. Biological aspects of cardiopulmonary bypass. J Cardiothorac Anesth 1990; 4:245–58.
<https://doi.org/10.1016/0888-6296(90)90246-C>
20. Lonsky V. Mimotělní oběh v klinické praxi. Grada Publishing a.s.,2004;94–100.
21. EA, Litvak J. Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst 1993; 85:862–8.
<https://doi.org/10.1093/jnci/85.11.862>
22. CF, Carr DT, Anderson WAD. A systém for the clinical staging of lung cancer. AJR 1974; 120:130–5.
<https://doi.org/10.2214/ajr.120.1.130>
23. CF. Revisions in the international systém for staging lung cancer. Chest 1997; 111:1710–21.
<https://doi.org/10.1378/chest.111.6.1710>
24. F, Verzini A, Zingarelli E, Summa M. Simultaneous operation for cardiac disease and lung cancer. Interactice Cardiovasc Thor Surg 2002; (1):69–71.
<https://doi.org/10.1016/S1569-9293(02)00034-8>
25. V, Thomas RJ, Wiesel RD, Komeda M, Cohen G, Ikonomidis JS, Christakis GT. Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg 1996; (62):342–6.
<https://doi.org/10.1016/0003-4975(96)00206-8>
26. J, Rešl M, Žáček P, Štětina M, Habal P. Chirurgická léčba plicní rakoviny. Acta Med (Hradec Králové) Suppl. 2001; 44:65–75.
27. KS Jr, Schmelzer V, Flege JB Jr, Todd JC, Mitts DL, Melvin DB, Wright CB. Concomitant cardiac and pulmonary operation:the role of cardiopulmonary bypass. Ann of Thor Surg 1992; (54):289–95.
<https://doi.org/10.1016/0003-4975(92)91387-O>
28. HC, Razzuk MA. Median sternotomy as a standard approach for pulmonary resection. Ann of Thor Surg 1986; (41):130–4.
<https://doi.org/10.1016/S0003-4975(10)62652-5>
29. J, Yamamoto T, Miyauchi Y. Is an increased leukotrine-generating capacity a specific phenomenon for cardiopulmonary bypass? J Thorac Cardiovasc Surg 1995; 110(1):276.
<https://doi.org/10.1016/S0022-5223(05)80040-6>
